Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome Region Maintenance Protein 1 (CRM1), also known as Exportin 1 (XPO1), is a highly conserved eukaryotic nuclear export receptor that plays a central role in the transport of proteins and RNAs from the nucleus to the cytoplasm. It mediates the nuclear export of a wide variety of proteins and ribonucleoproteins by recognizing specific amino acid sequences called nuclear export signals (NES) on cargo molecules. Dysregulation or overexpression of CRM1 has been implicated in several cancers, making it an attractive target for cancer therapy.
Small molecule inhibitors block NES-cargo binding, trapping tumor suppressors inside nuclei.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome Region Maintenance Protein 1 (CRM1).